SREBF2 and melanoma: Although the exact mechanism awaits further delineation, STM reduced SREBF2 abundance and hampered its involvement in the inflammatory response induced by IL‐1β [95], though SREBF2 has also been shown to paradoxically confer resistance to ferroptosis in circulating melanoma cells via directly activating the transcription of Tf [98].